Literature DB >> 8550049

Autoantibodies from patients with primary biliary cirrhosis recognize a region within the nucleoplasmic domain of inner nuclear membrane protein LBR.

F Lin1, C M Noyer, Q Ye, J C Courvalin, H J Worman.   

Abstract

Autoantibodies from rare patients with primary biliary cirrhosis (PBC) recognize LBR, or lamin B receptor, an integral membrane protein of the inner nuclear membrane. Human LBR has a nucleoplasmic, amino-terminal domain of 208 amino acids followed by a carboxyl-terminal domain with eight putative transmembrane segments. Autoantibodies against LBR from four patients with PBC recognized the nucleoplasmic, amino-terminal domain but not the carboxyl-terminal domain. Immunoblotting of smaller fusion proteins demonstrated that these autoantibodies recognized a conformational epitope(s) contained within the stretch of amino acids from 1 to 60. These results, combined with those of previous studies, show that autoepitopes of nuclear membrane proteins are located within their nucleocytoplasmic domains and that autoantibodies from patients with PBC predominantly react with one domain of a protein antigen. This work also provides further characterization of anti-LBR antibodies that have found utility as reagents in cell biology research.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550049     DOI: 10.1002/hep.510230109

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  12 in total

Review 1.  Autoantibodies as prognostic markers in autoimmune liver disease.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

2.  Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays.

Authors:  Chao-Jun Hu; Guang Song; Wei Huang; Guo-Zhen Liu; Chui-Wen Deng; Hai-Pan Zeng; Li Wang; Feng-Chun Zhang; Xuan Zhang; Jun Seop Jeong; Seth Blackshaw; Li-Zhi Jiang; Heng Zhu; Lin Wu; Yong-Zhe Li
Journal:  Mol Cell Proteomics       Date:  2012-05-30       Impact factor: 5.911

3.  Differential detection of nuclear envelope autoantibodies in primary biliary cirrhosis using routine and alternative methods.

Authors:  Elena Tsangaridou; Hara Polioudaki; Rania Sfakianaki; Martina Samiotaki; Maria Tzardi; Meri Koulentaki; George Panayotou; Elias Kouroumalis; Elias Castanas; Panayiotis A Theodoropoulos
Journal:  BMC Gastroenterol       Date:  2010-03-08       Impact factor: 3.067

Review 4.  Primary biliary cirrhosis: what do autoantibodies tell us?

Authors:  Chao-Jun Hu; Feng-Chun Zhang; Yong-Zhe Li; Xuan Zhang
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

5.  Solution structure and molecular interactions of lamin B receptor Tudor domain.

Authors:  Stamatis Liokatis; Christian Edlich; Katerina Soupsana; Ioannis Giannios; Parthena Panagiotidou; Konstantinos Tripsianes; Michael Sattler; Spyros D Georgatos; Anastasia S Politou
Journal:  J Biol Chem       Date:  2011-11-03       Impact factor: 5.157

Review 6.  Lamin B receptor: multi-tasking at the nuclear envelope.

Authors:  Ada L Olins; Gale Rhodes; David B Mark Welch; Monika Zwerger; Donald E Olins
Journal:  Nucleus       Date:  2010 Jan-Feb       Impact factor: 4.197

Review 7.  Autoantigens in primary biliary cirrhosis.

Authors:  D E Jones
Journal:  J Clin Pathol       Date:  2000-11       Impact factor: 3.411

8.  Peri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patients.

Authors:  Ourania Sfakianaki; Meri Koulentaki; Maria Tzardi; Elena Tsangaridou; Panayotis A Theodoropoulos; Elias Castanas; Elias A Kouroumalis
Journal:  World J Gastroenterol       Date:  2010-10-21       Impact factor: 5.742

9.  The nuclear pore complex protein Tpr is a common autoantigen in sera that demonstrate nuclear envelope staining by indirect immunofluorescence.

Authors:  Y Ou; P Enarson; J B Rattner; S G Barr; M J Fritzler
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

Review 10.  Autoantigens of the nuclear pore complex.

Authors:  P Enarson; J B Rattner; Y Ou; K Miyachi; T Horigome; M J Fritzler
Journal:  J Mol Med (Berl)       Date:  2004-06-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.